|drug1075||Dornase Alfa Inhalation Solution Wiki||1.00|
|D021821||Communicable Diseases, Emerging NIH||1.00|
|D003141||Communicable Diseases NIH||0.07|
There is one clinical trial.
The overall objective of this investigation is to understand the patient response to a robotic platform used to facilitate telehealth triage in the emergency department during the COVID-19 pandemic. The COVID-19 pandemic has altered the manner in which emergency department triage is completed. Attempts at cohorting individuals with potential COVID-19 disease in order to prevent disease transmission to healthcare workers and minimize the use of personal protective equipment (PPE) have renewed interest in telemedical solutions as a method to triage and manage individuals with COVID-19. This investigation deploys a legged robotic platform to facilitate agile, highly mobile telemedicine to manage COVID-19 patients in the emergency department. The primary objective is to measure the patient response to interacting with these systems.
Description: Quantitative questionnaire on the acceptance of virtual robotic care graded on a likert scale (higher scores better)Measure: Acceptance of robotic telehealth system Time: Immediately after completion of triage
Description: Quantitative questionnaire on the willingness to use this system again based on a likert scale (higher scores better)Measure: Willingness to interact with robotic telehealth system Time: Immediately after completion of triage
Description: Quantitative questionnaire on the user satisfaction with their triage experience (How satisfied were you with your experience interacting with the robotic system today?)Measure: Satisfaction of interacting with a robotic telehealth system Time: Immediately after completion of triage
Description: Quantitative questionnaire comparing robotic triage process with in-person triage: Do you think your interaction with the robotic system was better, the same or no different than an in-person evaluation?)Measure: Use of robotic system versus in-person triage Time: Immediately after completion of triage
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports